Segal et al. recruited 188 men (108 BRCA1, 80 BRCA2), and reported that 36% had a suspicious lesion on mpMRI and 8.5% were diagnosed with PCa; 44% of the tumours were classified as intermediate‐ or high‐risk diseases. The gene discussed is BRCA2; the disease is neoplasm.